Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1998 Aug;57(8):476–479. doi: 10.1136/ard.57.8.476

Distribution of macrovascular disease in scleroderma

L Stafford 1, H Englert 1, J Gover 1, J Bertouch 1
PMCID: PMC1752725  PMID: 9797553

Abstract

OBJECTIVE—Macrovascular disease in scleroderma has recently been described in two comparative studies. The aim of this study was to map its anatomical distribution.
METHODS—In a retrospective cohort study of 20 scleroderma patients, the results of Doppler studies of arteries in the limbs, neck, and abdomen were compared with those from 20 cohort negative patients. The latter were matched for age, sex, and the presence/absence of hypertension, hyperlipidaemia, smoking, and diabetes status. Arteries were compared quantitatively using a body surface area adjusted measurement of intraluminal diameter, and qualitatively using descriptive characteristics of the arterial walls. The latter were binomially categorised under three non-exclusive headings—thickening, stenosis, and calcification.
RESULTS—The ulnar arteries in scleroderma patients were significantly narrower than those of the negative cohort. The arterial walls were also characterised by smooth thickening along their entire length. The characteristics of the other arteries, including those of the lower limbs, were not significantly different from those of the negative cohort.
CONCLUSION—The ulnar artery seems to be specifically targeted in patients with scleroderma. Assessment of the ulnar artery should be considered in these patients by means of a modified Allen's test or Doppler sonography especially in the presence of digital gangrene.

 Keywords: scleroderma; ulnar artery; macrovascular disease

Full Text

The Full Text of this article is available as a PDF (91.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campbell P. M., LeRoy E. C. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum. 1975 May;4(4):351–368. doi: 10.1016/0049-0172(75)90017-7. [DOI] [PubMed] [Google Scholar]
  2. Conn J., Jr, Bergan J. J., Bell J. L. Hypothenar hammer syndrome: posttraumatic digital ischemia. Surgery. 1970 Dec;68(6):1122–1128. [PubMed] [Google Scholar]
  3. D'Angelo W. A., Fries J. F., Masi A. T., Shulman L. E. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969 Mar;46(3):428–440. doi: 10.1016/0002-9343(69)90044-8. [DOI] [PubMed] [Google Scholar]
  4. Dorevitch M. I., Clemens L. E., Webb J. B. Lower limb amputation secondary to large vessel involvement in scleroderma. Br J Rheumatol. 1988 Oct;27(5):403–406. doi: 10.1093/rheumatology/27.5.403. [DOI] [PubMed] [Google Scholar]
  5. Fuhrman T. M., Pippin W. D., Talmage L. A., Reilley T. E. Evaluation of collateral circulation of the hand. J Clin Monit. 1992 Jan;8(1):28–32. doi: 10.1007/BF01618084. [DOI] [PubMed] [Google Scholar]
  6. Furey N. L., Schmid F. R., Kwaan H. C., Friederici H. H. Arterial thrombosis in scleroderma. Br J Dermatol. 1975 Dec;93(6):683–693. doi: 10.1111/j.1365-2133.1975.tb05119.x. [DOI] [PubMed] [Google Scholar]
  7. Gaylis H., Kushlick A. R. The hypothenar hammer syndrome. S Afr Med J. 1976 Jan 31;50(5):125–127. [PubMed] [Google Scholar]
  8. Kaji H., Honma H., Usui M., Yasuno Y., Saito K. Hypothenar hammer syndrome in workers occupationally exposed to vibrating tools. J Hand Surg Br. 1993 Dec;18(6):761–766. doi: 10.1016/0266-7681(93)90240-g. [DOI] [PubMed] [Google Scholar]
  9. Klyscz T., Jünger M., Duda S., Rassner G. Hypothenar-Hammer-Syndrom als seltene Ursache eines Raynaud-Syndroms. Hautarzt. 1996 May;47(5):382–386. doi: 10.1007/s001050050436. [DOI] [PubMed] [Google Scholar]
  10. LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A., Jr, Rowell N., Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988 Feb;15(2):202–205. [PubMed] [Google Scholar]
  11. Lee J. E., Haynes J. M. Carotid arteritis and cerebral infarction due to scleroderma. Neurology. 1967 Jan;17(1):18–22. doi: 10.1212/wnl.17.1.18. [DOI] [PubMed] [Google Scholar]
  12. Merino J., Casanueva B., Piney E., Val Bernal F., Rodriguez-Valverde V. Hemiplegia and peripheral gangrene secondary to large and medium size vessels involvement in C.R.E.S.T. syndrome. Clin Rheumatol. 1982 Dec;1(4):295–299. doi: 10.1007/BF02032090. [DOI] [PubMed] [Google Scholar]
  13. Norton W. L., Nardo J. M. Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med. 1970 Aug;73(2):317–324. doi: 10.7326/0003-4819-73-2-317. [DOI] [PubMed] [Google Scholar]
  14. Pistorius M. A., de Faucal P., Planchon B., Grolleau J. Y. Intérêt du test d'Allen dans la recherche d'une artériopathie distale au cours du phénomène de Raynaud. Etude prospective sur une série continue de 576 patients. J Mal Vasc. 1994;19(1):17–21. [PubMed] [Google Scholar]
  15. Posner M. A., Herness D., Green S. Severe peripheral vascular deterioration in scleroderma. A case report. Acta Orthop Scand. 1980 Apr;51(2):239–241. doi: 10.3109/17453678008990792. [DOI] [PubMed] [Google Scholar]
  16. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980 May;23(5):581–590. doi: 10.1002/art.1780230510. [DOI] [PubMed] [Google Scholar]
  17. Reidy M. E., Steen V., Nicholas J. J. Lower extremity amputation in scleroderma. Arch Phys Med Rehabil. 1992 Sep;73(9):811–813. [PubMed] [Google Scholar]
  18. Spencer-Green G., Morgan G. J., Brown L., FitzGerald O. Hypothenar hammer syndrome: an occupational cause of Raynaud's phenomenon. J Rheumatol. 1987 Oct;14(5):1048–1051. [PubMed] [Google Scholar]
  19. Vayssairat M., Debure C., Cormier J. M., Bruneval P., Laurian C., Juillet Y. Hypothenar hammer syndrome: seventeen cases with long-term follow-up. J Vasc Surg. 1987 Jun;5(6):838–843. [PubMed] [Google Scholar]
  20. Veale D. J., Collidge T. A., Belch J. J. Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis. 1995 Oct;54(10):853–855. doi: 10.1136/ard.54.10.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Youssef P., Brama T., Englert H., Bertouch J. Limited scleroderma is associated with increased prevalence of macrovascular disease. J Rheumatol. 1995 Mar;22(3):469–472. [PubMed] [Google Scholar]
  22. Youssef P., Englert H., Bertouch J. Large vessel occlusive disease associated with CREST syndrome and scleroderma. Ann Rheum Dis. 1993 Jun;52(6):464–466. doi: 10.1136/ard.52.6.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Zimmerman N. B. Occlusive vascular disorders of the upper extremity. Hand Clin. 1993 Feb;9(1):139–150. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES